Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
NEW YORK (Reuters Health) – The results of a small phase II trial suggest that stereotactic body radiotherapy (SBRT), which involves a higher dose but shorter course than…
NEW YORK (Reuters Health) – The use of aspirin as a cardioprotective agent significantly reduces recurrence among patients being treated for high-grade, non-muscle-invasive bladder cancer, the results of…
NEW YORK (Reuters Health) – The results of the largest ovarian cancer screening trial to date suggest that a transvaginal ultrasound strategy or a multimodal approach that includes…
NEW YORK (Reuters Health) – Women with migraines during pregnancy are at increased risk for stroke, MI, and other vascular disorders, according to a report in the March…
NEW YORK (Reuters Health) – Contrary to findings from a Dutch study, the results of a Swedish study suggest that long-term dietary intake of acrylamide does not raise…
David M. Cognetti, MD, Assistant Professor of Otolaryngology – Head and Neck Surgery at Jefferson Medical College, discusses the evolution of treatment modalities for head and neck cancers.…
William Keane, MD, Professor of Otolaryngology – Head and Neck Surgery at Jefferson Medical College, discusses treatment for common head and neck cancers using surgery and chemo/radiotherapy. References…
David M. Cognetti, MD, Assistant Professor of Otolaryngology – Head and Neck Surgery at Jefferson Medical College, discusses optimal care for head and neck cancer patients. Sponsored by…
NEW YORK (Reuters Health) – High blood pressure accounts for some of the disproportionately higher mortality rates among African American patients with breast cancer compared with Caucasian patients,…
NEW YORK (Reuters Health) – An analysis of data from the Health Professionals Follow-up Study confirms that men with diabetes mellitus are less prone to develop prostate cancer…
